EVENT REPORT. European Food Safety Authority 3. European Food Safety Authority (EFSA), Parma, Italy

Size: px
Start display at page:

Download "EVENT REPORT. European Food Safety Authority 3. European Food Safety Authority (EFSA), Parma, Italy"

Transcription

1 Supporting Publications 2012:EN-317 EVENT REPORT Bilateral technical meeting between members of the EFSA Panels on Genetically Modified Organisms and Biological Hazards and the Austrian delegation on the national safeguard clause on GM potato EH , 2 ABSTRACT European Food Safety Authority 3 European Food Safety Authority (EFSA), Parma, Italy A bilateral technical meeting was held on 6 February 2012 between members of the EFSA Panels on Genetically Modified Organisms and Biological Hazards and Austrian experts to discuss issues related to the safeguard clause invoked by Austria for genetically modified (GM) potato EH The aim of the meeting was to listen to the arguments put forward by the Austrian delegation and to obtain clarification on scientific issues addressed in the Austrian document supporting its national safeguard clause on potato EH An observer from the European Commission (EC) presented the legal background and mandate by the EC. Scientific issues discussed related to the antibiotic resistance marker gene (nptii), the molecular characterisation and the postmarket environmental monitoring of GM potato EH European Food Safety Authority, 2012 KEY WORDS GMOs, potato, Solanum tuberosum, EH , Amflora, Austria, safeguard clause, human and animal health, environment, Directive 2001/18/EC 1 Question No EFSA-Q Disclaimer: The views or positions expressed in this publication do not necessarily represent in legal terms the official position of the European Food Safety Authority. The European Food Safety Authority assumes no responsibility or liability for any errors or inaccuracies that may appear. 3 Acknowledgement: EFSA wishes to thank the following members of the Joint GMO BIOHAZ Working Group on the Austrian safeguard clause for GM potato EH , Lieve Herman, Sirpa Kärenlampi and John Threlfall, and the following member of the GMO Working Group on Environment, Antoine Messéan, for the preparatory work on this scientific output and EFSA staff, Jaime Aguilera, Ana Gomes, Ernesto Liebana, Sylvie Mestdagh and Irina Olaru for the support provided to this scientific output. Any enquiries related to this output should be addressed to gmo@efsa.europa.eu Suggested citation: European Food Safety Authority; Bilateral technical meeting between members of the EFSA Panels on Genetically Modified Organisms and Biological Hazards and the Austrian delegation on the national safeguard clause on GM potato EH Supporting Publications 2012:EN-317. [9 pp.]. Available online: European Food Safety Authority, 2012

2 SUMMARY A bilateral technical meeting was held on 6 February 2012 between members of the EFSA Panels on Genetically Modified Organisms and Biological Hazards and Austrian experts to discuss issues related to the safeguard clause invoked by Austria for genetically modified (GM) potato EH The aim of the meeting was to listen to arguments put forward by the Austrian delegation and to obtain clarification on scientific issues addressed in the Austrian document supporting its national safeguard clause on potato EH An observer from the European Commission (EC) presented the legal background and mandate by the EC. Scientific issues discussed related to the antibiotic resistance marker gene (nptii), the molecular characterisation and the post-market environmental monitoring of GM potato EH Supporting publications 2012:EN-317 2

3 TABLE OF CONTENTS Abstract... 1 Summary... 2 Table of contents... 3 Background as provided by the European Commission... 4 Terms of reference as provided by the European Commission... 4 Consideration Introduction Presentation of legal background and mandate by the European Commission Introduction to the safeguard clause by the National Competent Authority and technical discussion Antibiotic resistance marker gene (nptii) Molecular characterisation Post-market environmental monitoring... 8 Conclusions... 8 Documentation provided to EFSA... 9 References... 9 Supporting publications 2012:EN-317 3

4 BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION In February 2006, the European Food Safety Authority (EFSA) adopted an opinion related to the placing on the market of GM potato EH for cultivation and industrial starch production, following a notification submitted by BASF Plant Science to the Swedish Authorities. On 2 March 2010, the European Commission (EC) adopted a decision authorising the placing on the market of GM potato EH for cultivation and industrial starch production. In June 2010, Austria notified to the European Commission its Ordinance BGBI. II No 125/2010 of 27/04/2010 implementing a national safeguard measure prohibiting the placing on the market of GM potato EH for cultivation purposes in Austria and provided scientific elements in support of its decision. In order for the EC to follow-up on this safeguard clause in accordance with Article 23 of Directive 2001/18/EC, it was deemed appropriate by EC that EFSA would assess the scientific elements provided by Austria. TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION EFSA was requested in accordance with Article 29 of Regulation (EC) No 178/2002 to assess the scientific information submitted by the Austrian Authorities justifying their national safeguard measure concerning GM potato EH and to identify whether these new scientific elements might lead the GMO Panel to reconsider its opinion on GM potato EH from Supporting publications 2012:EN-317 4

5 CONSIDERATION MINUTES OF THE MEETING The report below reflects the common understanding of EFSA and the Austrian delegation of the meeting held on 6 February This report is not, and cannot be regarded as, representative of the position, the views or the policy of the European Food Safety Authority or of any national or European Union institution, agency or body. Participants Austrian delegation Andreas Heissenberger Environment Agency Austria, Department of Land Use and Biosafety Sanda Pasc Alexandra Ribarits Dietmar Vybiral Federal Ministry of Health, Department of Genetic Engineering Austrian Agency for Health and Food Safety, Institute for Seed Head of the Delegation Federal Ministry of Health, Department of Genetic Engineering EFSA GMO Panel EFSA BIOHAZ Panel EFSA GMO Unit EFSA BIOHAZ Unit European Commission Markus Wögerbauer Austrian Agency for Health and Food Safety, Data Statistic Risk Assessment, GMO Risk Assessment Lieve Herman, Sirpa Kärenlampi, Antoine Messéan John Threlfall Ana Gomes, Sylvie Mestdagh, Irina Olaru, Elisabeth Waigmann (Chair) Ernesto Liebana Martine Delanoy, Sabine Pelsser (DG SANCO) In the course of a bilateral technical meeting (venue: video/telemeeting; duration: 2 hours) between experts from the EFSA Panels on Genetically Modified Organisms (GMO Panel) and Biological Hazards (BIOHAZ Panel) and Austrian experts, issues related to a safeguard clause invoked by Austria for potato EH were discussed. 1. Introduction Welcome The Acting Head of the EFSA GMO Unit chaired the meeting and welcomed the Austrian delegation, members of the EFSA GMO and BIOHAZ Panels and observers from the European Commission. The Chair clarified the aim of the bilateral meeting, which was to listen to the arguments put forward by the Austrian delegation and to obtain clarification on scientific issues addressed in the Austrian document supporting its national safeguard clause on potato EH The agenda of the meeting had been agreed upon by EFSA and the Austrian delegation during communication prior to the meeting. The Chair briefly went through the agreed agenda of the meeting by pointing out how the meeting would be structured and how the Austrian delegation would be given the opportunity to present its arguments. Supporting publications 2012:EN-317 5

6 Tour de table Participants introduced themselves during a tour de table. 2. Presentation of legal background and mandate by the European Commission A representative from the European Commission (EC, Directorate-General on Health and Consumers (DG SANCO)) recalled the historical and legal background of the Austrian safeguard clause under discussion. She explained that the Austrian national measure was subject to a request from the EC, directed to EFSA, to provide a scientific opinion based on the documents submitted by Austria. 3. Introduction to the safeguard clause by the National Competent Authority and technical discussion The Austrian delegation clarified its position, and arguments related to the use and safety of potato EH Concerning the antibiotic resistance marker (ARM) gene (nptii), the Austrian delegation confirmed that the main line of argument related to an ongoing research project the results of which cannot be discussed before the evaluation phase but which is expected to be completed at the end of This was again emphasised in response to a direct question from the BIOHAZ Panel member about the status of the current experimentation. In light of the lack of any new experimental evidence relating to transfer of the ntpii gene, the Austrian delegation proposed discussing the impacts and relevance of a low horizontal gene transfer frequency and the potential formation of mosaic genes involving nptii. The molecular characterisation and post-market environmental monitoring were also discussed Antibiotic resistance marker gene (nptii) An Austrian delegate highlighted the fact that a low horizontal gene transfer frequency (also acknowledged in the EFSA opinion on ARM; EFSA, 2009) could allow a rare event to occur and have significant relevance. As an example, the Austrian delegate referred to the formation of mosaic genes in the penicillin-binding proteins (PBPs) of Streptococcus pneumoniae and its public health consequences and asked the GMO and BIOHAZ Panels why they had not taken into account the formation of mosaic genes during their ARM gene risk assessment. An EFSA GMO Panel member indicated that mosaic genes in the context of antibiotic resistance are known only for highly transformable bacteria and certain antibiotic resistance genes. Mosaic genes have not been found among aminoglycoside phosphotransferase genes. In addition, the rate of DNA transfer between bacteria is higher than that from plant DNA to bacteria. For a recombination event and formation of a mosaic gene to occur, nptii would need to be present in bacteria in the environment. If this gene were already present in the environment, then the recombination frequency among bacteria would be expected to be much higher than between plant DNA and bacteria. Consequently, the potential risk of the formation of mosaic genes would be related to the environmental presence of the nptii gene in the bacterial community and to the fact that the bacteria to bacteria transfer rate is several orders of magnitude greater than that between plant DNA and bacteria. The Austrian delegate agreed that both the transfer and the recombination frequencies are higher among bacteria than those for the transfer and recombination of DNA from GM plants into bacteria. Nevertheless, a rare event (i.e. transfer of a mutated plant-derived nptii gene; involvement of plantderived copies of nptii in the formation of gene mosaics with resident nptii or other aminoglycoside phosphotransferase genes both potentially leading to alterations in the substrate specificity of the involved antibiotic resistance determinants) cannot be excluded, thereby resulting in possible clinical relevance (Heinemann and Traavik, 2004). The Austrian delegate also agreed that there is no published literature about the formation of mosaic genes among the seven classes of aminoglycoside phosphotransferases. But he was unaware of any scientific efforts targeted at looking systematically for the presence or absence of mosaic sequence patterns in aminoglycoside phosphotransferase genes. Thus, the absence of evidence could not be regarded a priori as evidence for the absence of that Supporting publications 2012:EN-317 6

7 phenomenon. According to the Austrian delegate the formation of mosaic genes is a common theme in bacterial evolution. As such, mosaic gene formation is not restricted to pbp genes or to highly transformable bacteria (van Hoek et al., 2008; Didelot and Maiden, 2010). Such mosaic gene formation should therefore be experimentally evaluated before drawing final conclusions on the potential risk of the nptii gene. As quantitative data on the prevalence of nptii on bacterial populations are also not available, conclusions on the prevalence of nptii cannot be drawn. An EFSA GMO Panel member asked the Austrian experts why a mosaic nptii gene would make a significant contribution to substrate specificity. The Austrian delegate explained his concern regarding the inactivation of amikacin, should the spectrum of substrate specificity be altered for nptii. He also referred to the example of S. pneumoniae, a case in which formation of mosaic genes occurred in spite of low frequency rates for the recombination of small DNA fragments Molecular characterisation An Austrian delegate made a general statement that Austria had found several shortcomings in the data contained in the applications for potato EH , as submitted to EFSA. These flaws increased the degree of uncertainty and did not allow Austria to draw reliable conclusions from the addressed data packages. The Chair reminded the participants that the safeguard clause was bound to address information made available after the date of consent for potato EH The Austrian delegates agreed that there had been no new data on the molecular characterisation of potato EH made available after the date of consent. The GMO Panel members agreed that the quality of data presented in the original potato EH dossiers was not perfect but reliable conclusions could be drawn by the GMO Panel on the basis of the total data package (EFSA, 2006a,b). The Austrian delegate pointed out the absence of data on the messenger RNA (mrna) expressed by the construct and that there could be different 3 ends, with a consequence for stability due to the loss of the nos terminator sequences. Moreover, he mentioned that the transgenic construct actually residing in EH was producing mrnas by convergent transcription starting in opposite directions from two flanking promoters leading to the formation of sirnas (small interfering RNAs), with potential pleiotropic silencing effects on other genes (Yan et al., 2006). The induction of RNA interference pathways was not intended by the initial application. Granule-bound starch synthase (GBSS) silencing was established on sodium dodecyl sulphate (SDS) polyacrylamide gel photos, which showed aberrant banding patterns besides the GBSS fragment between EH and the non-gm prevalent potato line. According to the Austrian delegate, both observations would require a thorough qualitative and quantitative analysis of the construct-derived GBSS mrna fragments and their effects on cellular metabolism. The applicant had failed to supply this information. Moreover, these convergent run-off mrna transcripts were the original effector molecules mediating the genetic modification, and thus should be dealt with and described in detail. A GMO Panel expert indicated that the lack of RNA analysis was not limiting, given that there were interpretable protein data demonstrating the loss of GBSS protein from the EH potato, which was the intended effect. The different banding pattern in the SDS-PAGE (polyacrylamide gel electrophoresis) analysis between the GM sample and the non-gm control was as might be expected. As in a non-gm potato starch 80 % of the extractable protein is GBSS, further evidence by Western blot analysis that the dominant correct-sized band was indeed GBSS was not considered necessary. It could also be expected that, in the absence of GBSS, other protein(s) dominate in a GM sample of similar total protein content. The (lower) band dominating in the GM sample was experimentally shown to be patatin, which is logical as patatins are a major protein family found in potato tubers. Stability has been addressed in the post-market environmental monitoring (PMEM) report, which has Supporting publications 2012:EN-317 7

8 just been received and evaluated by EFSA. The GMO Panel has concluded in its opinion on the PMEM report for potato EH that stability of the trait did not raise safety issues (EFSA, 2012) Post-market environmental monitoring An Austrian delegate indicated that the PMEM plan for potato EH , as submitted by the applicant, was very general and some exposure pathways (e.g. a possible increase in volunteers, the use of GM pulp for feed) had not been completely considered. The Austrian delegate also stressed that the changes in composition could lead to altered pest behaviour (e.g. making the GM potato more attractive to potato pests). The Austrian delegate also noted that the monitoring undertaken so far by the applicant and described in the monitoring report of 2010 did not fulfil the requirements of the authorisation decision, e.g. regarding studies to be carried out in the vicinity of the fields. A GMO Panel member noted that no new scientific knowledge had been provided by the Austrian Authorities indicating that changes in composition, such as those observed in potato EH , might significantly change its exposure to organisms feeding on potato or the persistence of potato EH over natural variation, or lead to adverse effects. The GMO Panel member also informed the meeting that the GMO Panel has recently assessed the 2010 PMEM report on potato EH , which included a specific field monitoring study on potato-feeding organisms in addition to general surveillance. On the basis of the available information, the outcomes of this 2010 report did not invalidate the conclusions of the previous risk assessment of potato EH by the EFSA GMO Panel. Although the EFSA GMO Panel had noted a number of weaknesses in the PMEM methodology and made several recommendations to improve the study design, there was no evidence that changes in composition in potato EH lead to adverse effects. As for exposure pathways, the GMO Panel member indicated that, in cases in which potato EH pulp is used as animal feed, the EFSA GMO Panel recommends that the Identity Preservation System, which already traces and records information on potato EH by-products, should be supplemented by the questionnaire outlined by the applicant. Regarding studies to be carried out in the vicinity of fields, the GMO Panel member mentioned that the above-mentioned assessment considered that outer rows cannot be the area that should be monitored as vicinity of the potato fields, acknowledged that the vicinity of potato fields might not be easy to define and requested the applicant to revise its definition of vicinity. Finally, the GMO Panel member acknowledged that there is always room to improve the methodology of the PMEM and that the PMEM strategy should not be seen as static but needs to be revised on a regular basis. CONCLUSIONS SUMMARISING REMARKS The Austrian delegation acknowledged the fruitful scientific discussion between the delegation and members of the EFSA GMO and BIOHAZ Panels and the opportunity to present its scientific arguments. In the absence of any new scientific data, the Austrian point of view was that these arguments justify the Austrian safeguard measure on potato EH The delegation agreed with the GMO Panel that, with regard to the PMEM, there is always room to improve the methodology. Furthermore, the PMEM strategy should not be seen as static but needs to be revised on a regular basis. The Austrian delegation appreciated that EFSA and its GMO and BIOHAZ Panels had dedicated this meeting to discussion of this Austrian safeguard clause. The EFSA GMO and BIOHAZ Panel experts were also thanked for the fruitful scientific discussion. Supporting publications 2012:EN-317 8

9 The Chair closed the meeting, thanking the Austrian delegation, the experts of the EFSA GMO and BIOHAZ Panels, and the observers from the European Commission. The Chair also informed the participants that a meeting report would be prepared by EFSA staff and sent for comments prior to publication. DOCUMENTATION PROVIDED TO EFSA 1. Letter, received 24 May 2011, with supporting document from Ladislav Miko, Deputy Director- General for the food chain EC, to Catherine Geslain-Lanéelle, Executive Director EFSA (ref SANCO/E1/SP/mb Ares(2011) ), requesting the assessment by EFSA of the scientific elements provided by Austria in support of its decision to implement a national safeguard measure under Article 23 of Directive 2001/18/EC for GM potato EH and comprising the following supporting document: REFERENCES Scientific arguments for an import ban of genetically modified potato (Solanum tuberosum L. line EH , notification C/SE/96/3501) in Austria. Didelot X and Maiden MC, Impact of recombination on bacterial evolution. Trends in Microbiology, 18(7), EFSA (European Food Safety Authority), 2006a. Opinion of the Scientific Panel on Genetically Modified Organisms on a request from the Commission related to the notification (Reference C/SE/96/3501) for the placing on the market of genetically modified potato EH with altered starch composition, for cultivation and production of starch, under Part C of Directive 2001/18/EC from BASF Plant Science. The EFSA Journal, 323, EFSA (European Food Safety Authority), 2006b. Opinion of the Scientific Panel on Genetically Modified Organisms on an application (Reference EFSA-GMO-UK ) for the placing on the market of genetically modified potato EH with altered starch composition, for production of starch and food/feed uses, under Regulation (EC) No 1829/2003 from BASF Plant Science. The EFSA Journal, 324, EFSA (European Food Safety Authority), Statement of EFSA on the consolidated presentation of the joint Scientific Opinion of the GMO and BIOHAZ Panels on the Use of Antibiotic Resistance Genes as Marker Genes in Genetically Modified Plants and the Scientific Opinion of the GMO Panel on Consequences of the Opinion on the Use of Antibiotic Resistance Genes as Marker Genes in Genetically Modified Plants on Previous EFSA Assessments of Individual GM Plants. The EFSA Journal, 1108, 1 8. EFSA (European Food Safety Authority), Scientific Opinion on the annual Post-Market Environmental Monitoring (PMEM) report from BASF Plant Science Company GmbH on the cultivation of genetically modified potato EH in EFSA Journal, 10(2):2558. Heinemann JA and Traavik T, Problems in monitoring horizontal gene transfer in field trials of transgenic plants. Nature Biotechnology, 22(9), van Hoek AH, Mayrhofer S, Domig KJ, Flórez AB, Ammor MS, Mayo B and Aarts HJ, Mosaic tetracycline resistance genes and their flanking regions in Bifidobacterium thermophilum and Lactobacillus johnsonii. Antimicrobial Agents and Chemotherapy, 52(1), Yan H, Chretien R, Ye J and Rommens CM, New construct approaches for efficient gene silencing in plants. Plant Physiology, 141(4), Supporting publications 2012:EN-317 9

COMMISSION OF THE EUROPEAN COMMUNITIES. Draft COMMISSION DECISION

COMMISSION OF THE EUROPEAN COMMUNITIES. Draft COMMISSION DECISION EN EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Draft Brussels, COMMISSION DECISION of authorising the placing on the market of food and feed containing, consisting of, or produced from the genetically

More information

How To Know If A Genetically Modified Potato Is Safe

How To Know If A Genetically Modified Potato Is Safe Opinion of the Scientific Panel on Genetically Modified Organisms on a request from the Commission related to the notification (Reference C/SE/96/3501) for the placing on the market of genetically modified

More information

COMMISSION IMPLEMENTING REGULATION (EU) No /.. of XXX

COMMISSION IMPLEMENTING REGULATION (EU) No /.. of XXX Ref. Ares(2013)222755-20/02/2013 EUROPEAN COMMISSION Brussels, XXX SANCO/12462/2011 Rev. 2 (POOL/E1/2011/12462/12462R2- EN.doc) [ ](2012) XXX draft COMMISSION IMPLEMENTING REGULATION (EU) No /.. of XXX

More information

Scientific Panel on Genetically Modified Organisms Minutes of the 73 rd meeting of the Working Group on Molecular Characterisation

Scientific Panel on Genetically Modified Organisms Minutes of the 73 rd meeting of the Working Group on Molecular Characterisation GENETICALLY MODIFIED ORGANISMS UNIT Scientific Panel on Genetically Modified Organisms Minutes of the 73 rd meeting of the Working Group on Molecular Characterisation Held on 16 17 June 2016, Parma (Agreed

More information

Chapter 23 Definitions of GMO/LMO and modern biotechnology. Three different definitions but the same legal interpretation?

Chapter 23 Definitions of GMO/LMO and modern biotechnology. Three different definitions but the same legal interpretation? Chapter 23 Definitions of GMO/LMO and modern biotechnology JAN HUSBY NORWEGIAN INSTITUTE OF GENE ECOLOGY (GENØK), TROMSØ, NORWAY Three different definitions but the same legal interpretation? There are

More information

Maize 1507: toxic and inadequately tested

Maize 1507: toxic and inadequately tested Maize 1507: toxic and inadequately tested Why GM maize 1507 should be banned December 2013 I. Summary A genetically modified maize that is tolerant to a particular herbicide and also produces its own insecticide

More information

EFSA meeting summary report EFSA AND GMO RISK ASSESSMENT FOR HUMAN AND ANIMAL HEALTH AND THE ENVIRONMENT. 14-15 September 2009, Brussels, Belgium

EFSA meeting summary report EFSA AND GMO RISK ASSESSMENT FOR HUMAN AND ANIMAL HEALTH AND THE ENVIRONMENT. 14-15 September 2009, Brussels, Belgium EFSA meeting summary report 4 ISSN 1725-9843 EFSA AND GMO RISK ASSESSMENT FOR HUMAN AND ANIMAL HEALTH AND THE ENVIRONMENT 14-15 September 2009, Brussels, Belgium Meeting summary report: EFSA and GMO Risk

More information

Overview on EFSA data requirements for the safety evaluation of food enzymes applications

Overview on EFSA data requirements for the safety evaluation of food enzymes applications Overview on EFSA data requirements for the safety evaluation of food enzymes applications Fidel Toldrá and Klaus-Dieter Jany EFSA CEF Panel Info session on Food Enzymes applications Parma, 27 May 2014

More information

Environmental Monitoring

Environmental Monitoring Environmental Monitoring For the import of oilseed rape from event T45 (ACS-BNØØ8-2) for food, feed and industrial uses 1. Introduction Authorisation holders have the obligation to implement, if appropriate,

More information

Pharmaceutical Biotechnology. Recombinant DNA technology Western blotting and SDS-PAGE

Pharmaceutical Biotechnology. Recombinant DNA technology Western blotting and SDS-PAGE Pharmaceutical Biotechnology Recombinant DNA technology Western blotting and SDS-PAGE Recombinant DNA Technology Protein Synthesis Western Blot Western blots allow investigators to determine the molecular

More information

European Commission Contract no. FIF.2004 0828: Users Guide to European Regulation in Biotechnology. Final Report, Part I: Complete text

European Commission Contract no. FIF.2004 0828: Users Guide to European Regulation in Biotechnology. Final Report, Part I: Complete text European Commission Contract no. FIF.2004 0828: Users Guide to European Regulation in Biotechnology Final Report, Part I: Complete text Page 1 USERS GUIDE TO EUROPEAN REGULATION IN BIOTECHNOLOGY CONTENTS

More information

CCR Biology - Chapter 9 Practice Test - Summer 2012

CCR Biology - Chapter 9 Practice Test - Summer 2012 Name: Class: Date: CCR Biology - Chapter 9 Practice Test - Summer 2012 Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Genetic engineering is possible

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Q5B

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Q5B INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE QUALITY OF BIOTECHNOLOGICAL PRODUCTS: ANALYSIS

More information

ORAL PRESENTATIONS RISK ASSESSMENT CHALLENGES IN THE FIELD OF ANIMAL WELFARE

ORAL PRESENTATIONS RISK ASSESSMENT CHALLENGES IN THE FIELD OF ANIMAL WELFARE ORAL PRESENTATIONS RISK ASSESSMENT CHALLENGES IN THE FIELD OF ANIMAL WELFARE Candiani D., Ribò O., Afonso A., Aiassa E., Correia S., De Massis F., Pujols J. and Serratosa J. Animal Health and Welfare (AHAW)

More information

Scientific Panel on Biological Hazards

Scientific Panel on Biological Hazards BIOLOGICAL HAZARDS AND CONTAMINANTS UNIT Scientific Panel on Biological Hazards Minutes of the 4 th meeting of the Working Group on the request for scientific and technical assistance concerning the revision

More information

Scientific Panel on Biological Hazards

Scientific Panel on Biological Hazards BIOLOGICAL HAZARDS AND CONTAMINANTS UNIT Scientific Panel on Biological Hazards Minutes of the 4 th meeting of the Working Group on the growth of spoilage bacteria during storage and transport of meat

More information

European Medicines Agency

European Medicines Agency European Medicines Agency July 1996 CPMP/ICH/139/95 ICH Topic Q 5 B Quality of Biotechnological Products: Analysis of the Expression Construct in Cell Lines Used for Production of r-dna Derived Protein

More information

Biosafety Council GUIDELINES TO COMPILE THE PUBLIC DOSSIER (NOVEMBER 2001) INFORMATION FOR THE NOTIFIER (VALID FOR 2002) G ENERAL INTRODUCTION

Biosafety Council GUIDELINES TO COMPILE THE PUBLIC DOSSIER (NOVEMBER 2001) INFORMATION FOR THE NOTIFIER (VALID FOR 2002) G ENERAL INTRODUCTION Biosafety Council Service of Biosafety and Biotechnology Dr W. Moens SECRETARIAT GUIDELINES TO COMPILE THE PUBLIC DOSSIER (NOVEMBER 2001) INFORMATION FOR THE NOTIFIER (VALID FOR 2002) G ENERAL INTRODUCTION

More information

Definition of Minimum Performance Requirements for Analytical Methods of GMO Testing European Network of GMO Laboratories (ENGL)

Definition of Minimum Performance Requirements for Analytical Methods of GMO Testing European Network of GMO Laboratories (ENGL) Definition of Minimum Performance Requirements for Analytical Methods of GMO Testing European Network of GMO Laboratories (ENGL) 13 October 2008 Date of application: 13 April 2009 INTRODUCTION The scope

More information

Manufacturing process of biologics

Manufacturing process of biologics Manufacturing process of biologics K. Ho Afssaps, France 2011 ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use 2011 ICH 1 Disclaimer:

More information

The EFSA Data Warehouse access rules

The EFSA Data Warehouse access rules TECHNICAL REPORT APPROVED: 23 February 2015 PUBLISHED: 27 February 2015 Abstract The EFSA Data Warehouse access rules European Food Safety Authority The European Food Safety Authority (EFSA) is in the

More information

Statement on a heat treatment to control Agrilus planipennis 1

Statement on a heat treatment to control Agrilus planipennis 1 EFSA Journal 2012;10(4):2646 ABSTRACT SCIENTIFIC OPINION Statement on a heat treatment to control Agrilus planipennis 1 EFSA Panel on Plant Health (PLH) 2, 3 European Food Safety Authority (EFSA), Parma,

More information

Statement of the Chief Medical Health Officer

Statement of the Chief Medical Health Officer Statement of the Chief Medical Health Officer June, 2011 Health Concerns About Cellular Phone Transmission Antennae and Base Stations In 2005, in response to community concerns and after reviewing the

More information

Guidelines on operational functioning of colleges

Guidelines on operational functioning of colleges EIOPA-BoS-14/146 EN Guidelines on operational functioning of colleges EIOPA Westhafen Tower, Westhafenplatz 1-60327 Frankfurt Germany - Tel. + 49 69-951119-20; Fax. + 49 69-951119-19; email: info@eiopa.europa.eu

More information

Statement of ethical principles for biotechnology in Victoria

Statement of ethical principles for biotechnology in Victoria Statement of ethical principles for biotechnology in Victoria Statement of ethical principles for biotechnology in Victoria Acknowledgments Published by the Public Health Group, Rural & Regional Health

More information

Appendix 2 Molecular Biology Core Curriculum. Websites and Other Resources

Appendix 2 Molecular Biology Core Curriculum. Websites and Other Resources Appendix 2 Molecular Biology Core Curriculum Websites and Other Resources Chapter 1 - The Molecular Basis of Cancer 1. Inside Cancer http://www.insidecancer.org/ From the Dolan DNA Learning Center Cold

More information

Recombinant DNA and Biotechnology

Recombinant DNA and Biotechnology Recombinant DNA and Biotechnology Chapter 18 Lecture Objectives What Is Recombinant DNA? How Are New Genes Inserted into Cells? What Sources of DNA Are Used in Cloning? What Other Tools Are Used to Study

More information

Annex 6: Nucleotide Sequence Information System BEETLE. Biological and Ecological Evaluation towards Long-Term Effects

Annex 6: Nucleotide Sequence Information System BEETLE. Biological and Ecological Evaluation towards Long-Term Effects Annex 6: Nucleotide Sequence Information System BEETLE Biological and Ecological Evaluation towards Long-Term Effects Long-term effects of genetically modified (GM) crops on health, biodiversity and the

More information

AP BIOLOGY 2007 SCORING GUIDELINES

AP BIOLOGY 2007 SCORING GUIDELINES AP BIOLOGY 2007 SCORING GUIDELINES Question 4 A bacterial plasmid is 100 kb in length. The plasmid DNA was digested to completion with two restriction enzymes in three separate treatments: EcoRI, HaeIII,

More information

Attivita del Laboratorio Europeo di Riferimento sugli OGM (EURL-GMFF) in supporto al sistema di controllo ufficiale degli Stati Membri

Attivita del Laboratorio Europeo di Riferimento sugli OGM (EURL-GMFF) in supporto al sistema di controllo ufficiale degli Stati Membri Roma IZSLT 30 Novembre 2010 1 Attivita del Laboratorio Europeo di Riferimento sugli OGM (EURL-GMFF) in supporto al sistema di controllo ufficiale degli Stati Membri Marco Mazzara Joint Research Centre,

More information

Chapter 3 Contd. Western blotting & SDS PAGE

Chapter 3 Contd. Western blotting & SDS PAGE Chapter 3 Contd. Western blotting & SDS PAGE Western Blot Western blots allow investigators to determine the molecular weight of a protein and to measure relative amounts of the protein present in different

More information

Parma, 22 August 2012 EFSA / Unit /GMO. Agreed by the WG on 22 August 2012

Parma, 22 August 2012 EFSA / Unit /GMO. Agreed by the WG on 22 August 2012 Parma, 22 August 2012 SCIENTIFIC PANEL ON GENETICALLY MODIFIED ORGANISMS Minutes of the 32 nd meeting of the Working Group on Genetically Modified Parma, 22 August 2012 EFSA / Unit /GMO Agreed by the WG

More information

SCIENTIFIC REPORT OF EFSA

SCIENTIFIC REPORT OF EFSA EFSA Journal 2012;10(10):2913 SCIENTIFIC REPORT OF EFSA Scientific and technical assistance on the minimum sample size to test should an annual BSE statistical testing regime be authorised in healthy slaughtered

More information

Biochemistry. Entrance Requirements. Requirements for Honours Programs. 148 Bishop s University 2015/2016

Biochemistry. Entrance Requirements. Requirements for Honours Programs. 148 Bishop s University 2015/2016 148 Bishop s University 2015/2016 Biochemistry The Biochemistry program at Bishop s is coordinated through an interdisciplinary committee of chemists, biochemists and biologists, providing students with

More information

Introductory Biotechnology for High School Teachers - UNC-Wilmington

Introductory Biotechnology for High School Teachers - UNC-Wilmington Workshop Dates: June 20-24, 2011 Introductory Biotechnology for High School Teachers - UNC-Wilmington Participants will learn basic scientific concepts and techniques in biotechnology, as well as how to

More information

Development of Environmental Indicators for Monitoring of Genetically Modified Plants

Development of Environmental Indicators for Monitoring of Genetically Modified Plants Texte 28/02 ENVIRONMENTAL RESEARCH OF THE FEDERAL MINISTRY OF THE ENVIRONMENT, NATURE CONSERVATION AND NUCLEAR SAFETY Research Report 299 89 405 UBA-FB 000219/e Development of Environmental Indicators

More information

Biotechnology: DNA Technology & Genomics

Biotechnology: DNA Technology & Genomics Chapter 20. Biotechnology: DNA Technology & Genomics 2003-2004 The BIG Questions How can we use our knowledge of DNA to: diagnose disease or defect? cure disease or defect? change/improve organisms? What

More information

COMMISSION STAFF WORKING DOCUMENT EXECUTIVE SUMMARY OF THE IMPACT ASSESSMENT. Accompanying the document. Proposal for a

COMMISSION STAFF WORKING DOCUMENT EXECUTIVE SUMMARY OF THE IMPACT ASSESSMENT. Accompanying the document. Proposal for a EUROPEAN COMMISSION Brussels, 6.5.2013 SWD(2013) 163 final COMMISSION STAFF WORKING DOCUMENT EXECUTIVE SUMMARY OF THE IMPACT ASSESSMENT Accompanying the document Proposal for a REGULATION OF THE EUROPEAN

More information

Handling impact assessments in Council

Handling impact assessments in Council QC-76-06-353-EN-C EN COUNCIL OF THE EUROPEAN UNION GENERAL SECRETARIAT Handling impact assessments in Council INDICATIVE GUIDANCE FOR WORKING PARTY CHAIRS ISBN 92-824-3284-X,!7IJ2I2-edcieg! kg611572cee_couv.indd

More information

The world of non-coding RNA. Espen Enerly

The world of non-coding RNA. Espen Enerly The world of non-coding RNA Espen Enerly ncrna in general Different groups Small RNAs Outline mirnas and sirnas Speculations Common for all ncrna Per def.: never translated Not spurious transcripts Always/often

More information

Comparison of regulatory frameworks of Austria, Germany, France, and South Tyrol for GM free labelling of food products

Comparison of regulatory frameworks of Austria, Germany, France, and South Tyrol for GM free labelling of food products Final Version October 11th, 2012 Comparison of regulatory frameworks of Austria, Germany, France, and South Tyrol for GM free labelling of food products Umweltbundesamt GmbH, Dr. Helmut Gaugitsch, Dr.

More information

AP Biology Syllabus 2012-2013

AP Biology Syllabus 2012-2013 n AP Biology, an emphasis is on students making connections between the big ideas within the AP Biology Curriculum Framework. he two main goals of AP Biology are to help students develop a conceptual framework

More information

FACULTY OF MEDICAL SCIENCE

FACULTY OF MEDICAL SCIENCE Doctor of Philosophy Program in Microbiology FACULTY OF MEDICAL SCIENCE Naresuan University 171 Doctor of Philosophy Program in Microbiology The time is critical now for graduate education and research

More information

GENE CLONING AND RECOMBINANT DNA TECHNOLOGY

GENE CLONING AND RECOMBINANT DNA TECHNOLOGY GENE CLONING AND RECOMBINANT DNA TECHNOLOGY What is recombinant DNA? DNA from 2 different sources (often from 2 different species) are combined together in vitro. Recombinant DNA forms the basis of cloning.

More information

BIOTECHNOLOGY OPERATIONS

BIOTECHNOLOGY OPERATIONS BIOTECHNOLOGY OPERATIONS Principles and Practices Michael J. Roy TECHNISCHE INFORMATION SBIBLIOTHEK UNIVERSITATSBIBLIOTHEK HANNOVER CRC Press TaylorStFrancis Croup Boca Raton London New York CRC Press

More information

Understanding the immune response to bacterial infections

Understanding the immune response to bacterial infections Understanding the immune response to bacterial infections A Ph.D. (SCIENCE) DISSERTATION SUBMITTED TO JADAVPUR UNIVERSITY SUSHIL KUMAR PATHAK DEPARTMENT OF CHEMISTRY BOSE INSTITUTE 2008 CONTENTS Page SUMMARY

More information

13.4 Gene Regulation and Expression

13.4 Gene Regulation and Expression 13.4 Gene Regulation and Expression Lesson Objectives Describe gene regulation in prokaryotes. Explain how most eukaryotic genes are regulated. Relate gene regulation to development in multicellular organisms.

More information

Submission of scientific peer-reviewed open literature for the approval of pesticide active substances under Regulation (EC) No 1107/2009 1, 2

Submission of scientific peer-reviewed open literature for the approval of pesticide active substances under Regulation (EC) No 1107/2009 1, 2 GUIDANCE OF EFSA - DRAFT Submission of scientific peer-reviewed open literature for the approval of pesticide active substances under Regulation (EC) No 1107/2009 1, 2 ABSTRACT European Food Safety Authority

More information

7- Master s Degree in Public Health and Public Health Sciences (Majoring Microbiology)

7- Master s Degree in Public Health and Public Health Sciences (Majoring Microbiology) 7- Master s Degree in Public Health and Public Health Sciences (Majoring Microbiology) Students should fulfill a total of 38 credit hours: 1- Basic requirements: 10 credit hours. 150701, 150702, 150703,

More information

http://www.springer.com/3-540-20178-5

http://www.springer.com/3-540-20178-5 http://www.springer.com/3-540-20178-5 92 3 Regulation, Assessment and Monitoring of GMOs 3.4.4 Field releases and Commercialisation of GMOs in CEE Countries Until 2003, only experimental field trial releases

More information

Course Curriculum for Master Degree in Food Science and Technology/ Department of Nutrition and Food Technology

Course Curriculum for Master Degree in Food Science and Technology/ Department of Nutrition and Food Technology Course Curriculum for Master Degree in Food Science and Technology/ Department of Nutrition and Food Technology The Master Degree in Food Science and Technology / Department of Nutrition and Food Technology,

More information

Comments from EASAC and FEAM on the In vitro diagnostic medical devices Regulation

Comments from EASAC and FEAM on the In vitro diagnostic medical devices Regulation Comments from EASAC and FEAM on the In vitro diagnostic medical devices Regulation Introduction The proposed Regulations on medical devices represent an important initiative to strengthen the characterisation

More information

RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES

RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES Guideline Title Radiopharmaceuticals based on Monoclonal Antibodies Legislative basis Directives 65/65/EEC, 75/318/EEC as amended, Directive 89/343/EEC

More information

BIOLOGY 101 COURSE SYLLABUS FOR FALL 2015

BIOLOGY 101 COURSE SYLLABUS FOR FALL 2015 BIOLOGY 101 COURSE SYLLABUS FOR FALL 2015 Course Description Instructor Biology 101 is the first of a two-semester introductory course sequence designed primarily for science majors. It covers some central

More information

The Public Health Research in Europe

The Public Health Research in Europe SPHERE Supplement Paper 3 Comment on SPHERE (Strengthening Public Health Research in Europe) literature reviews Professor William Dab, Health and Safety Department, Cnam Paris The work presented here is

More information

How To Coexist With Genetically Modified Crops

How To Coexist With Genetically Modified Crops Community research EUROPEAN COMMISSION CASE STUDIES GMO COEXISTENCE RESEARCH IN EUROPEAN AGRICULTURE Interested in European research? RTD info is our quarterly magazine keeping you in touch with main developments

More information

GUIDANCE DOCUMENT FOR COMPETENT AUTHORITIES FOR THE CONTROL OF COMPLIANCE WITH EU LEGISLATION ON:

GUIDANCE DOCUMENT FOR COMPETENT AUTHORITIES FOR THE CONTROL OF COMPLIANCE WITH EU LEGISLATION ON: EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL December 2012 GUIDANCE DOCUMENT FOR COMPETENT AUTHORITIES FOR THE CONTROL OF COMPLIANCE WITH EU LEGISLATION ON: Regulation (EU) No 1169/2011

More information

MASTER OF SCIENCE IN BIOLOGY

MASTER OF SCIENCE IN BIOLOGY MASTER OF SCIENCE IN BIOLOGY The Master of Science in Biology program is designed to provide a strong foundation in concepts and principles of the life sciences, to develop appropriate skills and to inculcate

More information

Lecture 13: DNA Technology. DNA Sequencing. DNA Sequencing Genetic Markers - RFLPs polymerase chain reaction (PCR) products of biotechnology

Lecture 13: DNA Technology. DNA Sequencing. DNA Sequencing Genetic Markers - RFLPs polymerase chain reaction (PCR) products of biotechnology Lecture 13: DNA Technology DNA Sequencing Genetic Markers - RFLPs polymerase chain reaction (PCR) products of biotechnology DNA Sequencing determine order of nucleotides in a strand of DNA > bases = A,

More information

GMO Risk Assessment - EU experiences and recent developments

GMO Risk Assessment - EU experiences and recent developments A future task in good hands GMO Risk Assessment - EU experiences and recent developments Beatrix Tappeser Head, Biosafety Division, BfN, Germany ENSSER - EEA Symposium on Science & Society 'Integrity of

More information

REGULATION REGULATION ON THE WORKING PROCEDURES AND PRINCIPLES OF RISK ASSESSMENT COMMITTEES AND COMMISSIONS SECTION ONE

REGULATION REGULATION ON THE WORKING PROCEDURES AND PRINCIPLES OF RISK ASSESSMENT COMMITTEES AND COMMISSIONS SECTION ONE 24 December 2011 SATURDAY Official Gazette No.: 28152 REGULATION From the Ministry of Food, Agriculture and Livestock: REGULATION ON THE WORKING PROCEDURES AND PRINCIPLES OF RISK ASSESSMENT COMMITTEES

More information

Green Fluorescent Protein (GFP): Genetic Transformation, Synthesis and Purification of the Recombinant Protein

Green Fluorescent Protein (GFP): Genetic Transformation, Synthesis and Purification of the Recombinant Protein Green Fluorescent Protein (GFP): Genetic Transformation, Synthesis and Purification of the Recombinant Protein INTRODUCTION Green Fluorescent Protein (GFP) is a novel protein produced by the bioluminescent

More information

DIRECTIVE 2014/32/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

DIRECTIVE 2014/32/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL 29.3.2014 Official Journal of the European Union L 96/149 DIRECTIVE 2014/32/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 26 February 2014 on the harmonisation of the laws of the Member States relating

More information

Protein immunoblotting

Protein immunoblotting Protein immunoblotting (Western blotting) Dr. Serageldeen A. A. Sultan Lecturer of virology Dept. of Microbiology SVU, Qena, Egypt seaas@lycos.com Western blotting -It is an analytical technique used to

More information

adopted on 22-23 March 2007

adopted on 22-23 March 2007 Statement of the Scientific Panel on Genetically Modified Organisms on the safe use of the nptii antibiotic resistance marker gene in genetically modified plants adopted on 22-23 March 2007 1. BACKGROUND

More information

Guidance Notes for Applicants of the Certificate for Clinical Trial on Medical Device

Guidance Notes for Applicants of the Certificate for Clinical Trial on Medical Device Guidance Notes for Applicants of the Certificate for Clinical Trial on Medical Device List of Contents Page 1. Introduction 1.1 The Medical Device Administrative Control System and the 3 proposed legislation

More information

AP Biology Essential Knowledge Student Diagnostic

AP Biology Essential Knowledge Student Diagnostic AP Biology Essential Knowledge Student Diagnostic Background The Essential Knowledge statements provided in the AP Biology Curriculum Framework are scientific claims describing phenomenon occurring in

More information

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy SCIENTIFIC OPINION Scientific Opinion on the substantiation of health claims related to foods with reduced lactose content and decreasing gastro-intestinal discomfort (ID 646, 1224, 1238, 1339) pursuant

More information

Molecular Biology And Biotechnology

Molecular Biology And Biotechnology in Molecular Biology And Biotechnology National Institute of Molecular Biology and Biotechnology College of Science University of the Philippines Diliman, Quezon City 1101 National Institute of Molecular

More information

CTY Genetics Syllabus

CTY Genetics Syllabus CTY Genetics Syllabus Week 1: Review and Mendelian Genetics What (DUE DATE) 1 Introduction and Review Morning Classroom Policies/ Ice Breaker Game/Introductions Syllabus Distribute Syllabus, Discuss Course

More information

Genetics Test Biology I

Genetics Test Biology I Genetics Test Biology I Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Avery s experiments showed that bacteria are transformed by a. RNA. c. proteins.

More information

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy SCIENTIFIC OPINION Scientific Opinion on the substantiation of health claims related to boron and prevention and treatment of prostate cancer (ID 221), maintenance of normal thyroid function (ID 222) and

More information

PRODUCTION AND QUALITY CONTROL OF MEDICINAL PRODUCTS DERIVED BY RECOMBINANT DNA TECHNOLOGY

PRODUCTION AND QUALITY CONTROL OF MEDICINAL PRODUCTS DERIVED BY RECOMBINANT DNA TECHNOLOGY PRODUCTION AND QUALITY CONTROL OF MEDICINAL PRODUCTS DERIVED BY RECOMBINANT DNA TECHNOLOGY Guideline Title Production and Quality Control of Medicinal Products derived by recombinant DNA Technology Legislative

More information

Response by Swedish authorities to the European Commission s public consultation on short selling

Response by Swedish authorities to the European Commission s public consultation on short selling Ministry of Finance Financial Institutions and Markets Fi2010/3634 10-5913 Financial Stability Department 2010-560-AFS European Commission Internal Markets and Services DG Financial Institutions markt-g3-consultations@ec.europa.eu

More information

Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: quality issues (revision 1)

Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: quality issues (revision 1) 22 May 2014 EMA/CHMP/BWP/247713/2012 Committee for Medicinal Products for Human Use (CHMP) Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance:

More information

Genetic Engineering in Plants and the New Breeding Techniques (NBTs) Inherent risks and the need to regulate. Dr. Ricarda A.

Genetic Engineering in Plants and the New Breeding Techniques (NBTs) Inherent risks and the need to regulate. Dr. Ricarda A. info@econexus.info www.econexus.info Briefing December 2015 Genetic Engineering in Plants and the New Breeding Techniques (NBTs) Inherent risks and the need to regulate Dr. Ricarda A. Steinbrecher Summary

More information

Vedlagt er inspill fra GenØk Senter for Biosikkerhet om høringer EFSA/GMO/ES/2012/104 for GHB614 bomull fra Bayer CropScience AG

Vedlagt er inspill fra GenØk Senter for Biosikkerhet om høringer EFSA/GMO/ES/2012/104 for GHB614 bomull fra Bayer CropScience AG Deres ref: 2013/1391 ART-BI-DHT Direktoratet for naturforvaltning Tungasletta 2 7485 Trondheim Dato: 11.03.2013 Vedlagt er inspill fra GenØk Senter for Biosikkerhet om høringer EFSA/GMO/ES/2012/104 for

More information

Message 791 Communication from the Commission - SG(2012) D/50777 Directive 98/34/EC Notification: 2011/0188/D

Message 791 Communication from the Commission - SG(2012) D/50777 Directive 98/34/EC Notification: 2011/0188/D Message 791 Communication from the Commission - SG(2012) D/50777 Directive 98/34/EC Notification: 2011/0188/D Reaction of the Commission to the response of a Member State notifying a draft regarding a

More information

DRAFT GUIDANCE DOCUMENT ON THE LOW VOLTAGE DIRECTIVE TRANSITION

DRAFT GUIDANCE DOCUMENT ON THE LOW VOLTAGE DIRECTIVE TRANSITION EUROPEAN COMMISSION Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs Industrial Transformation and Advanced Value Chains Advanced Engineering and Manufacturing Systems DRAFT

More information

Annual monitoring report on the cultivation of MON 810 in 2013

Annual monitoring report on the cultivation of MON 810 in 2013 Annual monitoring report on the cultivation of MON 810 in 2013 Czech Republic, Portugal, Romania, Slovakia, and Spain Submitted by MONSANTO EUROPE S.A. Dept. Regulatory Affairs Avenue de Tervuren 270-272

More information

EU Reference Laboratory for E. coli Department of Veterinary Public Health and Food Safety Unit of Foodborne Zoonoses Istituto Superiore di Sanità

EU Reference Laboratory for E. coli Department of Veterinary Public Health and Food Safety Unit of Foodborne Zoonoses Istituto Superiore di Sanità EU Reference Laboratory for E. coli Department of Veterinary Public Health and Food Safety Unit of Foodborne Zoonoses Istituto Superiore di Sanità Inventory of the expertise on molecular typing of Verocytotoxin-producing

More information

DECISIONS ADOPTED JOINTLY BY THE EUROPEAN PARLIAMENT AND THE COUNCIL

DECISIONS ADOPTED JOINTLY BY THE EUROPEAN PARLIAMENT AND THE COUNCIL L 218/82 EN Official Journal of the European Union 13.8.2008 DECISIONS ADOPTED JOINTLY BY THE EUROPEAN PARLIAMENT AND THE COUNCIL DECISION No 768/2008/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of

More information

Micro RNAs: potentielle Biomarker für das. Blutspenderscreening

Micro RNAs: potentielle Biomarker für das. Blutspenderscreening Micro RNAs: potentielle Biomarker für das Blutspenderscreening micrornas - Background Types of RNA -Coding: messenger RNA (mrna) -Non-coding (examples): Ribosomal RNA (rrna) Transfer RNA (trna) Small nuclear

More information

THROWING CAUTION TO THE WIND. A review of the European Food Safety Authority and its work on genetically modified foods and crops.

THROWING CAUTION TO THE WIND. A review of the European Food Safety Authority and its work on genetically modified foods and crops. THROWING CAUTION TO THE WIND A review of the European Food Safety Authority and its work on genetically modified foods and crops. November 2004 TABLE OF CONTENTS SUMMARY... 3 1. INTRODUCTION... 5 2. WHAT

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE E15

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE E15 INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE DEFINITIONS FOR GENOMIC BIOMARKERS, PHARMACOGENOMICS,

More information

Department of Microbiology Vidyasagar University Midnapore - 721 102 West Bengal

Department of Microbiology Vidyasagar University Midnapore - 721 102 West Bengal S'yllabus for the I 'year FG Diploma Course in QUALITY CONTROL AND ASSURANCE IN MICROBIAL TECHNOLOGY (Semester Based: 400 marks in two semesters) Department of Microbiology Vidyasagar University Midnapore

More information

cogem report cgm/090929-01 Building blocks for an eu sustainability assessment of genetically modified crops Cogem commissie genetische modificatie

cogem report cgm/090929-01 Building blocks for an eu sustainability assessment of genetically modified crops Cogem commissie genetische modificatie commissie Cogem genetische modificatie cogem report cgm/090929-01 SOCIo-economic aspects of gmos Building blocks for an eu sustainability assessment of genetically modified crops independent scientific

More information

Marketing Authorisation Of A Product In Czech Republic

Marketing Authorisation Of A Product In Czech Republic MARKETING AUTHORISATION APPLICATION FOR NEW PLANT PROTECTION PRODUCTS VIA THE MUTUAL RECOGNITION PROCEDURE AS SPECIFIED UNDER REGULATION (EC) No 1107/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

More information

Having regard to the Treaty establishing the European Community, and in particular Article 95(1) thereof,

Having regard to the Treaty establishing the European Community, and in particular Article 95(1) thereof, L 268/24 REGULATION (EC) No 1830/2003 OF THE EUROPEAN PARLIAMT AND OF THE COUNCIL of 22 September 2003 concerning the traceability and labelling of genetically modified organisms and the traceability of

More information

Phillips McDougall. The cost and time involved in the discovery, development and authorisation of a new plant biotechnology derived trait

Phillips McDougall. The cost and time involved in the discovery, development and authorisation of a new plant biotechnology derived trait R&D Study Phillips McDougall The cost and time involved in the discovery, development and authorisation of a new plant biotechnology derived trait A Consultancy Study for Crop Life International September

More information

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs Provisional Translation (as of January 27, 2014)* November 15, 2013 Pharmaceuticals and Bio-products Subcommittees, Science Board Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer

More information

Overview International course Plant Breeding

Overview International course Plant Breeding Overview International course Plant Breeding 2016-2018 The course and modules The international course Plant Breeding consists of 6 modules of 1 week in the period October 2016 until March 2018. In between

More information

Public Perceptions of Labeling Genetically Modified Foods

Public Perceptions of Labeling Genetically Modified Foods Public Perceptions of Labeling Genetically Modified Foods Working Paper 2013-01 William K. Hallman, Ph.D. Cara L. Cuite, Ph.D. Xenia K. Morin, Ph.D. Release date: November 1, 2013 For more information:

More information

Molecular Biology Techniques: A Classroom Laboratory Manual THIRD EDITION

Molecular Biology Techniques: A Classroom Laboratory Manual THIRD EDITION Molecular Biology Techniques: A Classroom Laboratory Manual THIRD EDITION Susan Carson Heather B. Miller D.Scott Witherow ELSEVIER AMSTERDAM BOSTON HEIDELBERG LONDON NEW YORK OXFORD PARIS SAN DIEGO SAN

More information

UNIVERSITY OF READING

UNIVERSITY OF READING UNIVERSITY OF READING MARKING CRITERIA CLASSIFICATION FRAMEWORK FOR TAUGHT POSTGRADUATE PROGRAMMES (for non-greenlands cohorts entering Autumn Term 2008 and thereafter) (for Greenlands cohorts entering

More information

In developmental genomic regulatory interactions among genes, encoding transcription factors

In developmental genomic regulatory interactions among genes, encoding transcription factors JOURNAL OF COMPUTATIONAL BIOLOGY Volume 20, Number 6, 2013 # Mary Ann Liebert, Inc. Pp. 419 423 DOI: 10.1089/cmb.2012.0297 Research Articles A New Software Package for Predictive Gene Regulatory Network

More information

UPBM CURRICULAR BROCHURE

UPBM CURRICULAR BROCHURE UPBM CURRICULAR BROCHURE Undergraduate Program in Biology and Medicine Contents Academic Year 2015-16 About the Undergraduate Program in Biology and Medicine...pg. 1 Undergraduate Majors...pg. 2-3 Getting

More information

Induction of Enzyme Activity in Bacteria:The Lac Operon. Preparation for Laboratory: Web Tutorial - Lac Operon - submit questions

Induction of Enzyme Activity in Bacteria:The Lac Operon. Preparation for Laboratory: Web Tutorial - Lac Operon - submit questions Induction of Enzyme Activity in Bacteria:The Lac Operon Preparation for Laboratory: Web Tutorial - Lac Operon - submit questions I. Background: For the last week you explored the functioning of the enzyme

More information

Genetic information (DNA) determines structure of proteins DNA RNA proteins cell structure 3.11 3.15 enzymes control cell chemistry ( metabolism )

Genetic information (DNA) determines structure of proteins DNA RNA proteins cell structure 3.11 3.15 enzymes control cell chemistry ( metabolism ) Biology 1406 Exam 3 Notes Structure of DNA Ch. 10 Genetic information (DNA) determines structure of proteins DNA RNA proteins cell structure 3.11 3.15 enzymes control cell chemistry ( metabolism ) Proteins

More information

Why Genetically Engineered (GE) Foods should be Labeled: Inadequate Regulations, Unanswered Safety Questions

Why Genetically Engineered (GE) Foods should be Labeled: Inadequate Regulations, Unanswered Safety Questions Why Genetically Engineered (GE) Foods should be Labeled: Inadequate Regulations, Unanswered Safety Questions Michael Hansen, Ph.D. Senior Scientist, Consumers Union Consumer Issues Conference 2014 Food:

More information